|
|
|
| Influencing factors of dropping-out from methadone maintenance treatment in Hangzhou City |
| YANG Bingsheng, CAO Chengjian
|
| Department of Methadone Outpatient, Hangzhou Occupational Disease Prevention and Control Hospital, Hangzhou, Zhejiang 310014, China |
|
|
|
|
Abstract Objective To analyze the factors affecting the dropping-out from methadone maintenance treatment (MMT) in Hangzhou City, so as to provide the evidence for improving the compliance to MMT. Methods One MMT clinic was sampled from each of the eight districts in Hangzhou City using a cluster random sampling method, and patients that received MMT and were at ages of 18 years and older and registered during the period from December 2020 through June 2021 were recruited. Participants' basic characteristics, illegality and crime within 6 months prior to MMT and family and social relationships were collected through questionnaire surveys, and factors affecting the dropping-out from MMT were identified using a multivariable logistic regression model. Results A total of 315 outpatients were included from MMT clinics. The participants had a mean age of (45.33±7.63) years, and included 245 men (77.78%) and 70 women (22.22%), with a dropping-out rate of 65.71%. Multivariable logistic regression analysis showed a low likelihood of dropping-out from MMT among patients at ages of 60 years and older (OR=0.080, 95%CI: 0.018-0.350), employees (OR=0.415, 95%CI: 0.236-0.727), patients without drug-related infectious diseases (OR=0.411, 95%CI: 0.231-0.731), patients with per dossing of 60 mL and higher (OR=0.431, 95%CI: 0.236-0.787) and patients without contact with drug-using friends (OR=0.328, 95%CI: 0.185-0.582), and a high possibility of dropping-out from MMT among patients with poor relationship with family members (OR=2.905, 95%CI: 1.127-7.488). Conclusion Age, working status, drug-related infectious diseases, dosing, relationship with family members and contact with drug-using friends affected the dropping-out from MTT in Hangzhou City.
|
|
Received: 23 February 2023
Revised: 19 April 2023
Published: 13 June 2023
|
|
|
|
|
|
[1] 中华人民共和国国家禁毒委员会.2021年中国毒情形势报告[EB/OL].[2023-04-19].http://www.nncc626.com/2022-06/23/c_1211659746.htm.
[2] 程曌,戴明妹,曹晓斌.中国美沙酮维持治疗者新型毒品滥用情况研究进展[J].中华流行病学杂志,2018,39(4):536-540.
[3] NONG T,HODGKIN D,TRANG N T,et al.A review of factors associated with methadone maintenance treatment adherence and retention in Vietnam[J/OL].Drug Alcohol Depend,2023[2023-04-19].https://doi.org/10.1016/j.drugalcdep.2022.109699.
[4] 阳凯,吴茜,汤恒,等.湖北省美沙酮维持治疗者退出状况及影响因素分析[J].中华流行病学杂志,2022,43(10):1645-1650.
[5] 熊成珠,王高喜,梁玉成.创建“三位一体”的美沙酮自助服药模式:经验,内涵和展望[J].中国药物滥用防治杂志,2022,28(1):12-18.
[6] 刘雪娇,罗巍,张波,等.基于Lasso-Logistic回归构建美沙酮维持治疗门诊患者继续使用毒品风险预测模型[J].中华疾病控制杂志,2021,25(12):1369-1373,1402.
[7] ALI N,AZIZ S A,NORDIN S,et al.Evaluation of methadone treatment in Malaysia:findings from the Malaysian Methadone Treatment Outcome Study(MyTOS)[J]. Subst Use Misuse,2018,53(2):239-248.
[8] SULLIVAN S G,WU Z,ROU K,et al.Who uses methadone services in China? Monitoring the world's largest methadone programme[J].Addiction,2015,110(Suppl.1):29-39.
[9] O'CONNOR A M,COUSINS G,DURAND L,et al. Retention of patients in opioid substitution treatment:a systematic review[J/OL]. PLoS One,2020,15(5)[2023-04-19].https://pubmed.ncbi.nlm.nih.gov/32407321/.DOI:10.1371/journal.pone.0232086.
[10] 戴明妹,程曌,曹晓斌.美沙酮维持治疗脱失影响因素研究进展[J].中国药物滥用防治杂志,2019,25(2):121-124.
[11] 叶小红,柏鸿凌,许圆圆,等.台州市美沙酮维持治疗人群特征分析[J].预防医学,2018,30(1):5-8.
[12] 黄悦勤. 医学科研中随机误差控制和样本量确定[J].中国心理卫生杂志,2015,29(11):874-880.
[13] 杜佳月,艾丽唤,唐艳艳,等.武汉市社区美沙酮维持治疗脱失现状及其影响因素[J].中国艾滋病性病,2020,26(4):402-406.
[14] 张广超,黎明,杨敬源,等.贵州省美沙酮维持治疗患者脱失原因分析[J].中华疾病控制杂志,2015,19(5):474-476.
[15] PROCTOR S L,COPELAND A L,KOPAK A M,et al.Predictors of patient retention in methadone maintenance treatment[J].Psychol Addict Behav,2015,29(4):906-917.
[16] 郑剑,赵丽娜,王大勇,等.温州市美沙酮维持治疗患者生存质量及影响因素研究[J].预防医学,2017,29(8):777-781.
[17] 范家诚,黄斌,马青,等.贵阳市美沙酮门诊治疗病人脱失影响因素分析[J].中华疾病控制杂志,2015,19(12):1215-1219.
[18] 陈国红,向婷,耿光伟,等.美沙酮维持治疗患者退出风险及影响因素[J].江苏预防医学,2018,29(5):488-490.
[19] 唐逸云,王永彬,钟晓妮.美沙酮维持治疗剂量的分类探索[J].中国药物滥用防治杂志,2019,25(4):199-202. |
|
|
|
